169 related articles for article (PubMed ID: 12909618)
21. Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis.
Ueda F; Tago K; Tamura H; Funakoshi-Tago M
J Biol Chem; 2017 Feb; 292(5):1826-1846. PubMed ID: 27998978
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin receptor and STAT5-specific pathways promote SKT6 cell hemoglobinization.
Gregory RC; Jiang N; Todokoro K; Crouse J; Pacifici RE; Wojchowski DM
Blood; 1998 Aug; 92(4):1104-18. PubMed ID: 9694697
[TBL] [Abstract][Full Text] [Related]
23. Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2.
Grebien F; Kerenyi MA; Kovacic B; Kolbe T; Becker V; Dolznig H; Pfeffer K; Klingmüller U; Müller M; Beug H; Müllner EW; Moriggl R
Blood; 2008 May; 111(9):4511-22. PubMed ID: 18239084
[TBL] [Abstract][Full Text] [Related]
24. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
[TBL] [Abstract][Full Text] [Related]
25. STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line.
Iwatsuki K; Endo T; Misawa H; Yokouchi M; Matsumoto A; Ohtsubo M; Mori KJ; Yoshimura A
J Biol Chem; 1997 Mar; 272(13):8149-52. PubMed ID: 9079629
[TBL] [Abstract][Full Text] [Related]
26. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
27. A common epitope is shared by activated signal transducer and activator of transcription-5 (STAT5) and the phosphorylated erythropoietin receptor: implications for the docking model of STAT activation.
Barber DL; Beattie BK; Mason JM; Nguyen MH; Yoakim M; Neel BG; D'Andrea AD; Frank DA
Blood; 2001 Apr; 97(8):2230-7. PubMed ID: 11290583
[TBL] [Abstract][Full Text] [Related]
28. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.
Ogilvie M; Yu X; Nicolas-Metral V; Pulido SM; Liu C; Ruegg UT; Noguchi CT
J Biol Chem; 2000 Dec; 275(50):39754-61. PubMed ID: 10995753
[TBL] [Abstract][Full Text] [Related]
29. Activation of the JAK1-STAT5 pathway by binding of the Friend virus gp55 glycoprotein to the erythropoietin receptor.
Yamamura Y; Senda H; Noda M; Ikawa Y
Leukemia; 1997 Apr; 11 Suppl 3():432-4. PubMed ID: 9209415
[TBL] [Abstract][Full Text] [Related]
30. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response.
Quelle FW; Wang D; Nosaka T; Thierfelder WE; Stravopodis D; Weinstein Y; Ihle JN
Mol Cell Biol; 1996 Apr; 16(4):1622-31. PubMed ID: 8657137
[TBL] [Abstract][Full Text] [Related]
31. [Proliferative signal transmission mediated by EpoR in leukemic cell lines].
Fan H; Kanji S; Zhai M
Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):294-7. PubMed ID: 11876995
[TBL] [Abstract][Full Text] [Related]
32. Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells.
Li K; Menon MP; Karur VG; Hegde S; Wojchowski DM
Blood; 2003 Nov; 102(9):3147-53. PubMed ID: 12869513
[TBL] [Abstract][Full Text] [Related]
33. Enhancing effects of co-transduction of both human erythropoietin receptor and c-kit cDNAs into hematopoietic stem/progenitor cells from cord blood on proliferation and differentiation of erythroid progenitors.
Dai MS; Heinrich MC; Broxmeyer HE; Lu L
Cytokines Cell Mol Ther; 2000 Mar; 6(1):1-8. PubMed ID: 10976533
[TBL] [Abstract][Full Text] [Related]
34. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
[TBL] [Abstract][Full Text] [Related]
35. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
Arcasoy MO; Karayal AF
Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
[TBL] [Abstract][Full Text] [Related]
36. Receptors that induce erythroid differentiation of Ba/F3 cells: structural requirements and effect on STAT5 binding.
Pless M; Norga K; Carroll M; Heim MH; D'Andrea AD; Mathey-Prevot B
Blood; 1997 May; 89(9):3175-85. PubMed ID: 9129020
[TBL] [Abstract][Full Text] [Related]
37. APS, an adaptor protein containing Pleckstrin homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-Cbl.
Wakioka T; Sasaki A; Mitsui K; Yokouchi M; Inoue A; Komiya S; Yoshimura A
Leukemia; 1999 May; 13(5):760-7. PubMed ID: 10374881
[TBL] [Abstract][Full Text] [Related]
38. Integrative signaling by minimal erythropoietin receptor forms and c-Kit.
Pircher TJ; Geiger JN; Zhang D; Miller CP; Gaines P; Wojchowski DM
J Biol Chem; 2001 Mar; 276(12):8995-9002. PubMed ID: 11124255
[TBL] [Abstract][Full Text] [Related]
39. Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways.
Um M; Lodish HF
J Biol Chem; 2006 Mar; 281(9):5648-56. PubMed ID: 16407271
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
